As the year comes to a close, LLS representatives were invited to visit the New York Stock Exchange (NYSE) today. LLS finishes 2013 nearing the $1 billion mark in investments in blood cancer research since our inception in 1949. These investments have helped advance breakthrough therapies to treat blood cancer patients.
To mark the occasion, LLS President and CEO John Walter rang the NYSE Closing Bell ®. Click here to see the actual bell ringing.